Treatment of seasonal affective disorder

Expert Review of Neurotherapeutics

Volumn 6, Issue 7, 2006, Pages 1039-1048

  Winkler, Dietmar ^a   Pjrek, Edda ^a   Iwaki, Rie ^b   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Antidepressants; Bright light therapy; Depression; Seasonal affective disorder

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; HYPERICUM EXTRACT; MELATONIN; MIRTAZAPINE; MOCLOBEMIDE; MODAFINIL; PSYCHOTROPIC AGENT; REBOXETINE; SERTRALINE;

CLINICAL TRIAL; CONSTIPATION; DIARRHEA; HUMAN; INSOMNIA; NAUSEA; PHOTOTHERAPY; REVIEW; SEASONAL AFFECTIVE DISORDER; URINE RETENTION; XEROSTOMIA;

BEHAVIOR THERAPY; CLINICAL TRIALS; COGNITIVE THERAPY; HUMANS; PHOTOTHERAPY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS; SEASONAL AFFECTIVE DISORDER; TREATMENT OUTCOME;

EID: 33745946709     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.6.7.1039     Document Type: Review

References (93)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). American Psychiatric Press, Washington, DC, USA (2000).
2. Winkler D, Pjrek E, Konstantinidis A, Stastny J, Kasper S. Seasonal affective disorder - pathophysiology and clinical management. Acta Psychiatr. Belg. 105, 141-148 (2005).
3. Kasper S, Rogers SL, Yancey A, Schulz PM, Skwerer RG, Rosenthal NE. Phototherapy in individuals with and without subsyndromal seasonal affective disorder. Arch. Gen. Psychiatry 46, 837-844 (1989).
4. Levitt AJ, Boyle MH, Joffe RT, Baumal Z. Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample. Can. J. Psychiatry 45(7), 650-654 (2000).
5. Kasper S, Kamo T. Seasonality in major depressed inpatients. J. Affect Disord. 19, 243-248 (1990).
6. Rosenthal NE, Sack DA, Gillin JC et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psychiatry 41, 72-80 (1984). First article on bright light therapy (BLT) in seasonal affective disorder (SAD).
7. Lewy AJ, Kern HA, Rosenthal NE, Wehr TA. Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am. J. Psychiatry 139, 1496-1498 (1982).
8. Winkler D, Willeit M, Praschak-Rieder N et al. Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample. Eur. Arch. Psychiatry Clin. Neurosci. 252(2), 54-62 (2002).
9. Winkler D, Pjrek E, Konstantinidis A et al. Anger attacks in seasonal affective disorder. Int. J. Neuropsychopharmacol. 9(2), 215-219 (2006).
10. Praschak-Rieder N, Willeit M, Neumeister A et al. Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. J. Affect Disord. 63(1-3), 239-242 (2001).
11. Dahl K, Avery DH, Lewy AJ et al. Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression. Acta Psychiatr. Scand. 88, 60-66 (1993).
12. Nathan PJ, Burrows GD, Norman TR. Melatonin sensitivity to dim white light in affective disorders. Neuropsychopharmacology 21, 408-413 (1999).
13. Danilenko KV, Putilov AA, Russkikh GS, Duffy LK, Ebbesson SO. Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med. Res. 53, 137-145 (1994).
14. Karadottir R, Axelsson J. Melatonin secretion in SAD patients and healthy subjects matched with respect to age and sex. Int. J. Circumpolar Health 60, 548-551 (2001).
15. Koorengevel KM, Beersma DG, den Boer JA, van den Hoofdakker RH. A forced desynchrony study of circadian pacemaker characteristics in seasonal affective disorder. J. Biol. Rhythms 17(5), 463-475 (2002).
16. Schwartz PJ, Turner EH, Garcia-Borreguero D et al. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects. Psychiatry Res. 86(1), 9-28 (1999).
17. Willeit M, Praschak-Rieder N, Neumeister A et al. [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol. Psychiatry 47, 482-489 (2000).
18. Neumeister A, Willeit M, Praschak-Rieder N et al. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol. Med. 31, 1467-1473 (2001).
19. Neumeister A, Turner EH, Matthews JR et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch. Gen. Psychiatry 55, 524-530 (1998).
20. Jang KL, Lam RW, Livesley WJ, Vernon PA. Gender differences in the heritability of seasonal mood change. Psychiatry Res. 70(3), 145-154 (1997).
21. Johansson C, Willeit M, Levitan R et al. The serotonin transporter promoter repeat length polymorphism, seasonal affective disorder and seasonality. Psychol. Med. 33, 785-792 (2003).
22. Parsey RV, Hastings RS, Oquendo MA et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am. J. Psychiatry 163, 48-51 (2006).
23. Willeit M, Praschak-Rieder N, Zill P et al. C825T polymorphism in the G protein β3-subunit gene is associated with seasonal affective disorder. Biol. Psychiatry 54, 682-686 (2003).
24. Johansson C, Willeit M, Smedh C et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28, 734-739 (2003).
25. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 10(8), 647-643 (2005).
26. Thompson C. Evidence-based treatment. In: Seasonal Affective Disorder. Partonen T, Magnusson A (Eds), Oxford University Press, NY, USA 151-158 (2001).
27. Golden RN, Gaynes BN, Ekstrom RD et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am. J. Psychiatry 162(4), 656-662 (2005).
28. Koorengevel KM, Gordijn MC, Beersma DG et al. Extraocular light therapy in winter depression: a double-blind placebo-controlled study. Biol. Psychiatry 50(9), 691-698 (2001).
29. Teicher MH, Glod CA, Oren DA et al. The phototherapy light visor: more to it than meets the eye. Am. J. Psychiatry 152(8), 1197-1202 (1995).
30. Joffe RT, Moul DE, Lam RW et al. Light visor treatment for seasonal affective disorder: a multicenter study. Psychiatry Res. 46(1), 29-39 (1993).
31. Leppamaki S, Meesters Y, Haukka J, Lonnqvist J, Partonen T. Effect of simulated dawn on quality of sleep - a community-based trial. BMC Psychiatry 3, 14 (2003).
32. Reme CE, Rol P, Grothmann K, Kaase H, Terman M. Bright light therapy in focus: lamp emission spectra and ocular safety. Technol. Health Care 4(4), 403-413 (1996).
33. Ruhrmann S, Kasper S, Hawellek B et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychol. Med. 28(4), 923-933 (1998). Evidence that BLT has a faster onset of action than fluoxetine.
34. Lam RW, Levitt AJ, Levitan RD et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am. J. Psychiatry 163(5), 805-812 (2006). Evidence that BLT has a faster onset of action than fluoxetine.
35. Lewy AJ, Bauer VK, Cutler NL et al. Morning vs evening light treatment of patients with winter depression. Arch. Gen. Psychiatry 55(10), 890-896 (1998). Provides evidence that morning BLT is superior to evening BLT.
36. Wirz-Justice A. Beginning to see the light. Arch. Gen. Psychiatry 55(10), 861-862 (1998).
37. Murray G, Michalak EE, Levitt AJ et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase? Chronobiol. Int. 22(5), 937-943 (2005).
38. Murray G, Michalak EE, Levitt AJ et al. O sweet spot where art thou? Light treatment of seasonal affective disorder and the circadian time of sleep. J. Affect Disord. 90(2-3), 227-231 (2006).
39. Winkler D, Pjrek E, Praschak-Rieder N et al. Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol. Psychiatry 58(4), 331-336 (2005).
40. Terman M, Terman JS. Bright light therapy: side effects and benefits across the symptom spectrum. J. Clin. Psychiatry 60(11), 799-808 (1999).
41. Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am. J. Ophthalmol. 119(2), 202-210 (1995).
42. Dureau P, Jeanny JC, Clerc B, Dufier JL, Courtois Y. Long term light-induced retinal degeneration in the miniature pig. Mol. Vis. 2, 7 (1996).
43. Praschak-Rieder N, Neumeister A, Hesselmann B, Willeit M, Barnas C, Kasper S. Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. J. Clin. Psychiatry 9, 389-392 (1997).
44. Swiecicki L. Phototherapy for winter depression: report of three cases. Psychiatr. Pol. 27, 667-672 (1993).
45. Pjrek E, Winkler D, Willeit M, Konstantinidis A, Thierry N, Kasper S. Menstrual disturbances a rare side-effect of bright-light therapy. Int. J. Neuropsychopharmacol. 7, 239-240 (2004).
46. Pjrek E, Winkler D, Stastny J, Konstantinidis A, Heiden A, Kasper S. Bright light therapy in seasonal affective disorder - does it suffice? Eur. Neuropsychopharmacol. 14(4), 347-351 (2004).
47. Lam RW, Gorman CP, Michalon M et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am. J. Psychiatry 152(12), 1765-1770 (1995).
48. Moscovitch A, Blashko CA, Eagles JM et al. A placebo-controlled study of sertraline in the treatment of out-patients with seasonal affective disorder. Psychopharmacology (Berl.) 171(4), 390-397 (2004).
49. Martiny K, Lunde M, Simonsen C et al. Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatr. Scand. 109(3), 230-234 (2004).
50. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62 (1960).
51. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr. Scand. 59, 420-430 (1979).
52. Hesselmann B, Habeler A, Praschak Rieder N, Willeit M, Neumeister A, Kasper S. Mirtazapine in seasonal affective disorder (SAD): a preliminary report. Human Psychopharmacology Clinical and Experimental 14(1), 59-62 (1999).
53. Hilger E, Willeit M, Praschak-Rieder N, Stastny J, Neumeister A, Kasper S. Reboxetine in seasonal affective disorder: an open trial. Eur. Neuropsychopharmacol. 11(1), 1-5 (2001). First small study investigating the efficacy and tolerability of a selective noradrenergic antidepressant in SAD.
54. Modell JG, Rosenthal NE, Harriett AE et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol. Psychiatry 58(8), 658-667 (2005). Very important study investigating a preventative treatment strategy in a very large SAD sample.
55. Partonen T, Lonnqvist J. Moclobemide and fluoxetine in treatment of seasonal affective disorder. J. Affect Disord. 41(2), 93-99 (1996).
56. Lundt L. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study. J. Affect Disord. 81(2), 173-178 (2004). Interesting open study investigating the effectiveness and tolerability of modafinil in SAD.
57. Martinez B, Kasper S, Ruhrmann S, Moller HJ. Hypericum in the treatment of seasonal affective disorders. J. Geriatr. Psychiatry Neurol. 7(Suppl. 1), S29-S33 (1994).
58. Wheatley D. Hypericum in seasonal affective disorder (SAD). Curr. Med. Res. Opin. 15(1), 33-37 (1999).
59. Leppamaki S, Partonen T, Vakkuri O, Lonnqvist J, Partinen M, Laudon M. Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour. Eur. Neuropsychopharmacol. 13(3), 137-145 (2003).
60. Kennedy SH, Emsley R. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur. Neuropsychopharmacol. 16(2), 93-100 (2006).
61. Wirz-Justice A, Graw P, Krauchi K et al. 'Natural' light treatment of seasonal affective disorder. J. Affect Disord. 37(2-3), 109-120 (1996).
62. Richter P, Bouhugs AL, van den Hoofdakker RH et al. Imaginary versus real light for winter depression. Biol. Psychiatry 31(5), 534-536 (1992). Interesting study with quite innovative methodology.
63. Pinchasov BB, Shurgaja AM, Grischin OV, Putilov AA. Mood and energy regulation in seasonal and nonseasonal depression before and after midday treatment with physical exercise or bright light. Psychiatry Res. 94(1), 29-42 (2000).
64. Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch. Gen. Psychiatry 55(10), 875-882 (1998).
65. Goel N, Terman M, Terman JS, Macchi MM, Stewart JW. Controlled trial of bright light and negative air ions for chronic depression. Psychol. Med. 35(7), 945-955 (2005).
66. Graw P, Haug HJ, Leonhardt G, Wirz-Justice A. Sleep deprivation response in seasonal affective disorder during a 40-h constant routine. J. Affect Disord. 48(1), 69-74 (1998).
67. Neumeister A, Goessler R, Lucht M, Kapitany T, Bamas C, Kasper S. Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation. Biol. Psychiatry 39(1), 16-21 (1996).
68. Avery DH, Holtzheimer PE 3rd, Fawaz W et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol. Psychiatry 59(2), 187-194 (2006).
69. Konstantinidis A, Heiden A, Stastny J et al. Rapid transcranial magnetic stimulation (r-TMS): A novel treatment option for seasonal affective disorder (SAD)? Eur. Neuropsychopharm. 12(Suppl.), 252 (2002). First pilot study to investigate rapid transcranial magnetic stimulation in a small sample of SAD patients.
70. Meesters Y. Other therapies. In: Seasonal Affective Disorder. Partonen T, Magnusson A (Eds), Oxford University Press, NY, USA 95-102 (2001).
71. Rohan KJ, Lindsey KT, Roecklein KA, Lacy TJ. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J. Affect Disord. 80(2-3), 273-283 (2004).
72. Winkler D, Praschak-Rieder N, Willeit M et al. Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics. Nervenarzt 73(7), 637-643 (2002).
73. Konstantinidis A, Winkler D. Lichttherapie: Parameter und praktische Hinweise zur Anwendung. In: Herbst-/Winterdepression und Lichttherapie. Kasper S, Möller HJ (Eds), Springer, Wien, NY, USA 133-144 (2004).
74. Dilsaver SC, Jaeckle RS. Winter depression responds to an open trial of tranylcypromine. J. Clin. Psychiatry 51(8), 326-329 (1990).
75. Teicher MH, Glod CA. Seasonal affective disorder: rapid resolution by low-dose alprazolam. Psychopharmacol. Bull. 26(2), 197-202 (1990).
76. Dilsaver SC, Qamar AB, Del Medico VJ. The efficacy of bupropion in winter depression: results of an open trial. J. Clin. Psychiatry 53(7), 252-255 (1992).
77. Lingjaerde O Haggag A. Moclobemide in winter depression: some preliminary results from an open trial. Nordic Journal of Psychiatry 46(3), 201-203 (1992).
78. Wirz Justice A, Van der Velde P, Bucher A, Nil R. Comparison of light treatment with citalopram in winter depression: a longitudinal single case study. International Clinical Psychopharmacology 7(2), 109-116 (1992).
79. Yamadera H, Okawa M, Takahashi K. Open study of effects of alprazolam on seasonal affective disorder. Psychiatry Clin. Neurosci. 55(1), 27-30 (2001).
80. Shen J, Kennedy SH, Levitan RD, Kayumov L, Shapiro CM. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. J. Psychiatry Neurosci. 30(1), 11-16 (2005).
81. Ghadirian AM, Murphy BE, Gendron MJ. Efficacy of light versus tryptophan therapy in seasonal affective disorder. J. Affect Disord. 50(1), 23-27 (1998).
82. Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J. Nutr. Health Aging 3(1), 5-7 (1999).
83. Rosenthal NE, Jacobsen FM, Sack DA et al. Atenolol in seasonal affective disorder: a test of the melatonin hypothesis. Am. J. Psychiatry 145(1), 52-56 (1988).
84. O'Rourke D, Wurtman JJ, Wurtman RJ, Chebli R, Gleason R. Treatment of seasonal depression with d-fenfluramine. J. Clin. Psychiatry 50(9), 343-347 (1989).
85. McGrath RE, Buckwald B, Resnick EV. The effect of L-tryptophan on seasonal affective disorder. J. Clin. Psychiatry 51(4), 162-163 (1990).
86. Oren DA, Teicher MH, Schwartz PJ et al. A controlled trial of cyanocobalamin (vitamin B12) in the treatment of winter seasonal affective disorder. J. Affect Disord. 32(3), 197-200 (1994).
87. Oren DA, Moul DE, Schwartz PJ, Wehr TA, Rosenthal NE. A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis. J. Clin. Psychopharmacol. 14(3), 196-200 (1994).
88. Schlager DS. Early-morning administration of short-acting β blockers for treatment of winter depression. Am. J. Psychiatry 151(9), 1383-1385 (1994).
89. Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatry Res. 77(1), 57-61 (1998).
90. Lingaerde O, Foreland AR, Magnusson A. Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial. Acta Psychiatr. Scand. 100(1), 62-66 (1999).
91. Thorell LH, Kjellman B, Arned M, Lindwall-Sundel K, Walinder J, Wetterberg L. Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year followup. Int. Clin. Psychopharmacol. 14(Suppl. 2), S7-S11 (1999).
92. Turner EH, Schwartz PJ, Lowe CH et al. Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder. J. Clin. Psychopharmacol. 22(2), 216-220 (2002).
93. Lewy AJ, Lefler BJ, Hasler BP, Bauer VK, Bernert RA, Emens JS. Plasma DLMO10 zeitgeber time 14: the therapeutic window for phase-delayed winter depressives treated with melatonin. Chronobiol. Int. 20, 1215-1217 (2003).